John Kiely is Director at Amneal Pharmaceuticals, Inc. (AMRX). They have made 6 open-market trades across 2 companies since 2020, most recently 2026-08-13.
CIK 0001781149
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $87K since 2020, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMRX | 200,252 | $3.8M |
| ZVO | 71,865 | $7K |
| Total | $3.8M |
Shares reported on the most recent Form 4, priced at the 2026-08-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMRX | SELL | 2026-08-13 | 2026-08-14 | $17.64 | $882K | +0.2% | -4.0% | — |
| AMRX | SELL | 2025-08-27 | 2025-08-28 | $9.23 | $295K | +2.5% | +3.0% | +30.7% |
| AMRX | SELL | 2025-05-12 | 2025-05-13 | $7.59 | $380K | -4.1% | +6.6% | +18.3% |
| AMRX | SELL | 2024-11-22 | 2024-11-26 | $8.38 | $286K | -1.9% | -4.8% | +0.6% |
| ZVO | BUY | 2020-09-08 | 2020-09-10 | $4.26 | $43K | +2.1% | +16.0% | +6.2% |
| AMRX | BUY | 2020-05-19 | 2020-05-19 | $4.40 | $44K | +3.3% | +7.4% | -6.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.